ArticleExperimental hematology & oncology2022

Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways.

Qinwei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.